Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-014139
Filing Date
2025-05-13
Accepted
2025-05-13 17:48:38
Documents
1
Period of Report
2025-05-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5986
  Complete submission text file 0001127602-25-014139.txt   7689
Mailing Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
DEBBANE RAYMOND (Reporting) CIK: 0001053890 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30111 | Film No.: 25941793

Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Issuer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)